Two-Year trial tests Long-Term safety of weekly injection for rare gut condition
NCT ID NCT04881825
Summary
This is a two-year extension study for adults with short bowel syndrome who completed a previous trial. It aims to see if weekly injections of glepaglutide remain safe and effective over the long term. The study will monitor side effects and whether the treatment continues to help patients reduce their need for intravenous nutrition support.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SHORT BOWEL SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Asklepios Kliniken Hamburg GmbH
Hamburg, Germany
-
Centre Hospitalier Lyon-Sud
Pierre-Bénite, France
-
Charité - Universitätsmedizin Berlin
Berlin, Germany
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Hôpital Beaujon
Clichy, France
-
Mayo Clinic College of Medicin
Rochester, Minnesota, 55905, United States
-
Norfolk and Norwich University Hospitals
Norwich, United Kingdom
-
Rigshospitalet
Copenhagen, Denmark
-
St Mark's Hospital
Harrow, United Kingdom
-
Szpital Skawina sp. z o.o. im. Stanley Dudricka
Skawina, Poland
-
UCLH Foundation NHS Trust
London, United Kingdom
-
UMC Radboud Nijmegen
Nijmegen, Netherlands
-
Universitair Ziekenhuis Leuven
Leuven, Belgium
-
University of Nebraska Medical Center
Omaha, Nebraska, 68198, United States
-
Universitätsklinikum Bonn
Bonn, 53127, Germany
-
Universitätsklinikum Frankfurt
Frankfurt, Germany
-
Universitätsmedizin Rostock
Rostock, Germany
-
Vanderbilt University Medical Center, Nashville
Nashville, Tennessee, 68198-3285, United States
-
Wojewodzki Specjalistyczny Szpital im. M. Pirogowa w Lodzi
Lodz, Poland
Conditions
Explore the condition pages connected to this study.